Data Bridge Market Research Added new completed report titled Global
Topical Drug Delivery Market Segmentation By Product Type (Topical Drug
Delivery Formulations (Solid, Liquid, Semi Solid), Transdermal Drug Delivery
Devices (Transdermal Patches, Transdermal Gels)), By End-User (Hospitals,
Clinics, Home Healthcare, Diagnostic Centers, Others), By Distribution Channel
(Direct Tenders, Retail), By Geography (North America, Europe, Asia-Pacific,
Latin America, Rest of the World) and Forecast to 2024
Global Topical Drug Delivery Market is expected to
reach USD 205.1 billion by 2024 from USD 101.7 billion in 2016, growing at a
CAGR of 9.2% in the forecast period 2017 to 2024. The new market report
contains data for historic years 2015, the base year of calculation is 2016 and
the forecast period is 2017 to 2024.
This report consists of
below pages:
• No of pages: 246
• No of Figures: 17
• No of Tables: 271
Drivers included Topical Drug Delivery Market:
Some of the major factors driving the topical drug delivery
market are ability to deliver drug at the desired site, inter-and intra-patient
variations, without fluctuations in drug levels, an enhanced suitability for
self-medication and improved compliance. Also, increasing aging population, growing
prevalence of skin related ailments and rising prevalence of chronic diseases,
also new and better technologies for topical drug delivery is expected to boost
the growth of this market are the major factors driving the growth of the
injectable drug delivery market.
Request for Free Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-topical-drug-delivery-market
Rising Cases of Acute and Chronic Diseases
The prevalence of diseases and conditions such as infections
which includes bacterial infection and fungal infections, inflammations, pain
management, acne, sun burns, psoriasis, dermatitis, skin allergy, skin cancer,
diabetes, and many others has increased considerably over a period of time.
Rising Aging Population
With the increasing age, the cases of acute and chronic diseases
are rising. Older population is more prone to diseases such as diabetes,
allergy, arthritis, infections, and dermatitis.
Technological Advancements and Innovations
With the rising prevalence of acute and chronic diseases it has
become important for the drug and device manufacturers to develop advanced
technologies that will provide more effective treatment for the diseases. In
the few years, many developments took place for the topical drug delivery due
to the rapid absorption of drugs.
Approval of New Drugs
With the increasing demand for the treatment of diseases using
painless and non-invasive method the demand for topical drug delivery is
increasing.
Better Opportunity in Pharmerging Markets
According to Data Bridge Market Research analysts, Japan, Europe
and North America are expected to account for around 73% of total global pharmaceutical
market, while the rest of the world only own 27% of the market.
Inquiry about this Report visit @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-topical-drug-delivery-market
Major Key Players:
·
Galderma Pharma, S.A.,
·
Allergen Plc. Kaken Pharmaceuticals, Co., Ltd,
·
Pfizer,
·
Bayer AG,
·
3M,
·
Hisamitsu Pharmaceuticals, Co., Inc.,
·
Abbvie, Inc.,
·
Valeant Pharmaceuticals,
·
Antares Pharma
·
Among others.
Read more about this Report visit @ http://databridgemarketresearch.com/reports/global-topical-drug-delivery-market/
Table of Content:
1. INTRODUCTION
2. RESEARCH
METHODOLOGY
3. MARKET
LANDSCAPE SUMMARY
4. PREMIUM
INSIGHTS
5. EXECUTIVE
SUMMARY
6. TOPICAL
DRUG DELIVERY MARKET, BY PRODUCT TYPE
7. TOPICAL
DRUG DELIVERY MARKET, BY END-USER
8. TOPICAL
DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
9. TOPICAL
DRUG DELIVERY MARKET, BY GEOGRAPHY
9.1. COUNTRYWISE DRUG DELIVERY DEVICES MARKET, (ALL SEGMENTATION
PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
10. TOPICAL
DRUG DELIVERY MARKET: COMPETITIVE LANDSCAPE
11. TOPICAL
DRUG DELIVERY MARKET, COMPANY PROFILES
11.1. JANSSEN PHARMACEUTICALS, INC. (A J&J COMPANY)
11.2. CRESCITA THERAPEUTICS
11.3. GALDERMA S.A.
11.4. BIOFARMITALIA S.R.L
11.5. PHARMATEK LABORATORIES, INC.
11.6. STIEFEL LABORATORIES, INC.
11.7. TAPEMARK
11.8. NITTO DENKO CORPORATION
11.9. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
11.9. MYLAN PHARMACEUTICALS INC.
11.9. HISAMITSU PHARMACEUTICAL CO., INC.
11.10. THERASOLVE NV.
11.11. SAMYANG BIOPHARMACEUTICALS CORPORATION
11.12. LOHMANN THERAPIE-SYSTEME AG
11.13. PROSOLLUS PHARMACEUTICALS
11.14. EASTON PHARMACEUTICALS INC.
11.15. ANTARES PHARMA, INC.
11.16. ENDO PHARMACEUTICALS INC.
11.17. TRANSDERMAL TECHNOLOGIES, INC.
11.18. SHEFFIELD PHARMACEUTICALS, INC.
11.19. SOLVAY
11.20. 3M DRUG DELIVERY SYSTEMS
Related Report
North America Contraceptive Devices Market – Industry Trends and
Forecast to 2024
North America Contraceptive Devices Market, By Product Type, By
End-User, By Distribution Channel, By Country (U.S., Canada, Mexico) – Industry
Trends and Forecast to 2024
Report Access: http://databridgemarketresearch.com/reports/north-america-contraceptive-devices-market/
About Data Bridge Market Research:
Data Bridge Market Research set
forth itself as an unconventional and neoteric Market research and consulting
firm with unparalleled level of resilience and integrated approaches. We are
determined to unearth the best market opportunities and foster efficient
information for your business to thrive in the market. Data Bridge endeavors to
provide appropriate solutions to the complex business challenges and initiates
an effortless decision-making process.
Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research